Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LGND > SEC Filings for LGND > Form 8-K on 12-Jun-2013All Recent SEC Filings

Show all filings for LIGAND PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for LIGAND PHARMACEUTICALS INC


12-Jun-2013

Submission of Matters to a Vote of Security Holders


Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2013 annual meeting of stockholders of Ligand Pharmaceuticals Incorporated (the "Company") was held on June 11, 2013. Set forth below is a brief description of each matter voted on at the meeting and the final voting results.

Proposal 1. The election of eight members of the Company's board of directors for terms expiring at the 2014 annual meeting of stockholders. In accordance with the results below, each nominee was elected to serve as a director.

                                                 Votes
                              Votes For        Withheld        Broker Non-Votes
         Jason Aryeh           12,197,870       2,940,747              3,892,549
         Todd C. Davis         14,911,964         226,653              3,892,549
         John L. Higgins       14,859,195         279,422              3,892,549
         David M. Knott        11,372,843       3,765,774              3,892,549
         John W. Kozarich      14,914,957         223,660              3,892,549
         John L. LaMattina     14,914,868         223,749              3,892,549
         Sunil Patel           11,516,875       3,621,742              3,892,549
         Stephen L. Sabba      11,510,104       3,628,513              3,892,549

Proposal 2. The ratification of the Audit Committee's selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2013. In accordance with the results below, the selection of Grant Thornton LLP was approved.

Votes For Votes Against Abstentions Broker Non-Votes 18,776,022 99,807 155,337 -

Proposal 3. The approval of the compensation of the named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. In accordance with the results below, the advisory resolution approving the compensation of the Company's named executive officers was approved.

Votes For Votes Against Abstentions Broker Non-Votes 14,819,895 158,452 160,270 3,892,549

No other matters were submitted for stockholder action.


  Add LGND to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LGND - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.